Trials / Unknown

UnknownNCT05936112

Quantification of Fecal Calprotectin Concentration Difference Between Infants Aged Under 4 Months Old Suffering From Functional Gastrointestinal Disorders (FGID) and Infants Aged Under 4 Months Old Free From Disorders : a Transversal Case-control Monocentric Study

Status: Unknown
Phase: N/A
Study type: Interventional
Enrollment: 100 (estimated)

Sponsor: Centre Hospitalier Universitaire de Besancon · Academic / Other
Sex: All
Age: 0 Months – 4 Months
Healthy volunteers: Not accepted

Summary

There is a high prevalence of FGID among infants : 30 % for regurgitations, 20 % for colitis , 15 % for functional constipation.This represents a frequent motive for pediatrics consultation : 23 to 28 % of medical consultations in this population are consequent to gastrointestinal symptoms among infants aged under 4 months old. This can lead to numerous inappropriate or unrecommended medication prescriptions. Currently, fecal calprotectin threshold are only validated by science societies for children aged 5 years old and more. This study aims to quantify the difference of fecal calprotectin between a population of infants for whom no FGID has been finally detected, and a population of infants for whom FGID have been detected during the gastro-pediatrics consultation, , in order to later determine wether it is possible to validate a threshold in a population of infants aged under 4 months old.

Conditions

Interventions

Type	Name	Description
OTHER	Fecal calprotectin dosage	Dosing calprotectin in infants' feces + questionnaire/interview with parents
OTHER	Questionnaire and interview with parents	Dosing calprotectin in infants' feces + questionnaire/interview with parents

Timeline

Start date: 2023-09-01
Primary completion: 2024-04-01
Completion: 2024-04-01
First posted: 2023-07-07
Last updated: 2023-07-07

Source: ClinicalTrials.gov record NCT05936112. Inclusion in this directory is not an endorsement.